Clinical Trial Update: CEST- Glucose Enhanced MRI for Metastatic Brain Tumours [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CEST glucose-enhanced MRI for metastatic brain tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Brain Neoplasms, Malignant, Metastasis | Phase 2 | Status: TERMINATED